PlainRecalls
FDA Drug Moderate Class II Ongoing

Pantoprazole Sodium Delayed Release Tablets USP 40mg, 1000-count bottles, Rx only, Manufactured for: Camber Pharmaceuticals Inc., Piscataway, NJ, 08854, By: Hetero Labs Limited, Unit V, Polepally, Jadcherla, Mahabubnagar- 509 301, India NDC 31722-713-10

Reported: April 19, 2023 Initiated: March 14, 2023 #D-0530-2023

Product Description

Pantoprazole Sodium Delayed Release Tablets USP 40mg, 1000-count bottles, Rx only, Manufactured for: Camber Pharmaceuticals Inc., Piscataway, NJ, 08854, By: Hetero Labs Limited, Unit V, Polepally, Jadcherla, Mahabubnagar- 509 301, India NDC 31722-713-10

Reason for Recall

CGMP Deviations: Discoloration

Details

Recalling Firm
Hetero USA Inc
Units Affected
2,352 bottles
Distribution
Nationwide within the United States
Location
Piscataway, NJ

Frequently Asked Questions

What product was recalled?
Pantoprazole Sodium Delayed Release Tablets USP 40mg, 1000-count bottles, Rx only, Manufactured for: Camber Pharmaceuticals Inc., Piscataway, NJ, 08854, By: Hetero Labs Limited, Unit V, Polepally, Jadcherla, Mahabubnagar- 509 301, India NDC 31722-713-10. Recalled by Hetero USA Inc. Units affected: 2,352 bottles.
Why was this product recalled?
CGMP Deviations: Discoloration
Which agency issued this recall?
This recall was issued by the FDA Drug on April 19, 2023. Severity: Moderate. Recall number: D-0530-2023.